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A B S T R A C T
Methylglyoxal (MG) is a highly reactive aldehyde spontaneously formed in human cells mainly as a by-product
of glycolysis. Such endogenous metabolite reacts with proteins, nucleotides and lipids forming advanced gly-
cation end-products (AGEs). MG binds to arginine, lysine and cysteine residues of proteins causing the formation
of stable adducts that can interfere with protein function. Among the proteins affected by glycation, MG has been
found to react with superoxide dismutase 1 (SOD1), a fundamental anti-oxidant enzyme that is abundantly
expressed in neurons. Considering the high neuronal susceptibility to MG-induced oxidative stress, we sought to
investigate by mass spectrometry and NMR spectroscopy which are the structural modifications induced on
SOD1 by the reaction with MG. We show that MG reacts preferentially with the disulfide-reduced, demetallated
form of SOD1, gradually causing its unfolding, and to a lesser extent, with the intermediate state of maturation –
the reduced, zinc-bound homodimer – causing its gradual monomerization. These results suggest that MG could
impair the correct maturation of SOD1 in vivo, thus both increasing cellular oxidative stress and promoting the
cytotoxic misfolding and aggregation process of SOD1.
1. Introduction
While the human body comes in contact with most toxic substances
through the diet, through the environment, or generally through ex-
posure to exogenous agents, some endogenous compounds, which are
derived from the physiological cell metabolism, can be extremely
harmful, if the mechanisms dedicated to their neutralization fail. This is
the case of methylglyoxal (MG), a highly reactive α-oxoaldehyde, po-
tentially formed in all mammalian cells mainly as a by-product of the
metabolism of the triosephosphate intermediates of glucose [1,2].
Specifically, during glycolysis, MG is formed from the spontaneous
degradation of glyceraldehyde-3-phosphate (GAP) and dihydrox-
yacetone phosphate (DHAP) [3–5]. Literature reports that about
0.1%–0.4% of the glycolytic flux results in the formation of this highly
reactive dicarbonyl [6]. Additional precursors of MG include amino-
acetone, derived from the catabolism of proteins [1,2,7], and ketone
bodies, derived from lipid peroxidation [8].
The detoxification of MG and other reactive aldehydes is performed
by the glyoxalase system [9]. In eukaryotes, such system is composed
by two cytosolic thiol-dependent catalytic enzymes: during a first step,
glyoxalase I (Glo1) catalyses the isomerisation of the hemithioacetal,
formed by the spontaneous reaction of MG with glutathione (GSH), to
the intermediate S-D-lactoylglutathione; subsequently, glyoxalase II
(Glo2) converts S-D-lactoylglutathione to D-lactate, restoring the GSH
consumed during the first reaction [9].
Intracellular MG can reach micromolar concentrations [10], and its
levels reflect a balance between the cellular glycolytic rate and the
detoxification efficiency of the glyoxalase system [3]. Specifically, the
tissue levels of MG have been quantified in mice, in which it can reach
concentrations up to 4.3 μM in the hepatocytes [11]. MG is a potent
electrophile that reacts with proteins, nucleotides and phospholipids
forming stable adducts called advanced glycation end-products (AGEs)
[5]. MG is known to irreversibly modify proteins by spontaneously
reacting with the side chains of arginine, lysine and cysteine residues
[12–15]. Reaction of MG with the guanidinium group of arginine leads
to the formation of three possible isomers of methylglyoxal hydro-
imidazolone (MG-H1, MG-H2 and MG-H3); subsequently, MG-H3 can
form N7-carboxyethyl arginine (CEA) upon the addition of a water
molecule (Fig. 1a) [15]. When MG interacts with the ε-NH2 of lysine, it
forms N-ε-(carboxyethyl)lysine (CEL, Fig. 1b). MG can also interact
with the sulfhydryl group of cysteine forming a hemimercaptal (Fig. 1c)
[13]. Moreover, CEL and the cysteine hemimercaptal can potentially
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form inter or intra-molecular adducts by reacting with a NH2 group
from the same or other molecules (Fig. 1d) [13].
The reaction between MG and proteins, nucleotides or lipids, which
results in the gradual accumulation of AGEs in tissues, has been related
with aging and with several pathologies including hypertension, car-
diovascular diseases, diabetes, cancer and neurodegenerative diseases
[3,13,16–20].
Due to their high rate of glucose consumption and oxidative meta-
bolism, neurons are likely more exposed to MG than other types of cells
[3]. In fact, several studies demonstrated the neurotoxic effects of MG
associated with oxidative stress and the accumulation of AGEs
[3,21–26].
Among the affected proteins, it has been reported that MG can react
with the metalloenzyme superoxide dismutase 1 (SOD1), causing the
loss of enzymatic activity due to the release of the copper ion from
Cu,Zn-SOD1 catalytic site [27], together with the formation of MG-in-
duced protein aggregates [28]. Similarly, it has been shown that
glyoxal, another highly reactive dialdehyde able to form AGEs, can
react with SOD1 to form stable adducts [29]. Furthermore, ex vivo ex-
periments reported that SOD1 extracted from erythrocytes of diabetic
patients is significantly more glycated and has a lower enzymatic ac-
tivity, with respect to controls [30]. SOD1 is an essential anti-oxidant
metalloenzyme that catalyses the dismutation of O2•- to H2O2 and O2
with very high reaction rates [31–33]. Consistent with a decrease of
intracellular SOD1 activity, it has been shown that MG causes a sig-
nificant increase of intracellular NO and O2•– levels [34]. Furthermore,
it has been hypothesised that the release of the highly reactive copper
ion in the cellular environment could contribute to increase the
Fig. 1. MG reaction with amino acid residues of proteins. MG reacts with arginine forming MG-H1, MG-H2 and MG-H3 isoforms, the last of which generates CEA
upon hydrolysis (a); MG reacts with lysine forming CEL (b); MG reacts with cysteine forming hemimercaptal (c), which in turn can further react with a free amino
(NH2) group forming a stable adduct (d).
Fig. 2. SDS-PAGE electrophoresis performed on the apo-SOD1SH (a) and E,Zn-SOD1SH (b) incubated with MG. Lane 1: control; lane 2: no MG, 5 h; lane 3: 1 mMMG,
5 h; lane 4: 5 mM MG, 5 h; lane 5: 30 mM MG, 5 h; lane 6: no MG, 24 h; lane 7: 1 mM MG, 24 h; lane 8: 5 mM MG, 24 h; lane 9: 30 mM MG, 24 h; lane 10: no MG,
48 h; lane 11: 1 mM MG, 48 h; lane 12: 5 mM MG, 48 h; lane 13: 30 mM MG, 48 h.
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production of reactive oxygen species (ROS) [26]. Therefore, the MG-
induced inactivation of SOD1 has been related to the increase of oxi-
dative stress, that in turn is associated with aging and other patholo-
gical states [18]. Despite these premises, it is not yet clear whether MG-
induced decrease of SOD1 cellular activity occurs as a consequence of
MG reacting with the fully mature, disulfide-containing enzyme, Cu,Zn-
SOD1SS, or instead the reaction between MG and the immature forms of
SOD1 is responsible for the incomplete protein maturation and sub-
sequent structural destabilization, that could lead to the loss of enzy-
matic activity reported in the literature.
Therefore, we sought to investigate the reaction between MG and
the immature forms of SOD1 through Nuclear Magnetic Resonance
(NMR) spectroscopy and Mass Spectrometry (MS), to determine whe-
ther MG has preferential reactivity for one of these forms, and which
structural modifications occur on the protein. Specifically, we focused
on the initial state of the protein after synthesis: the apo, disulfide-re-
duced monomer (apo-SOD1SH), which is partially unfolded, exposes the
dimer interface residues to the solvent and has a higher aggregation
propensity [35], and on the zinc-containing, disulfide-reduced dimer
(E,Zn-SOD1SH), which is a stable intermediate maturation state that
precedes chaperone-assisted copper binding and disulfide bond for-
mation [36–38].
2. Materials and methods
2.1. Protein purification and demetallation
The human recombinant SOD1 was purified implementing an ex-
isting protocol [39]. E. coli BL21(DE3) Gold cells were transformed with
a pET28a plasmid encoding the wt SOD1 gene. The cells were grown at
37 °C in LB medium (or in 15N-labelled M9 medium for the NMR ex-
periments), supplemented with 100 μM ZnSO4, until mid-log phase.
Consequently, the cells were induced with 0.5 mM isopropyl-β-D-1-
tiogalattopiranoside (IPTG), and grown for an additional 4 h at 30 °C.
The cells were then harvested, re-suspended in 20 mM Tris, 50 μM
ZnSO4, 1 M DTT, pH 8, supplemented with protease inhibitor tablets
(cOmplete ULTRA, EDTA-free, Roche) and lysed by sonication (3 s ON,
10 s OFF, at 60% of amplitude for 40 min). After clarification, the lysate
was loaded on a DEAE Sepharose Fast Flow (GE Healthcare) anion
exchange column and eluted with NaCl gradient. The fractions con-
taining SOD1 were further purified by a Superdex 75 26/600 column
(GE Healthcare) size exclusion column, eluting with 20 mM Tris,
150 mM NaCl, pH 8. The fractions containing SOD1 were collected and
checked by SDS-PAGE (AnyKD, Bio-Rad).
hSOD1 was demetallated as previously described [40,41]. Briefly,
the protein underwent 10 repeated dialyses (at least 8 h each): 7x
dialysis against 10 mM EDTA in 50 mM acetic acid at pH 3.7, followed
by 1x dialysis against 50 mM acetic acid at pH 3.7, and 2x consecutive
dialyses against 50 mM acetic acid at pH 5.5. Finally, the buffer was
replaced with PBS, pH 7.4. The reduction of the disulfide bond of SOD1
was performed by incubating the apo-SOD1SS with 50 mM of DTT for
40’ at 37 °C. Finally, DTT was removed washing the buffer with oxygen-
free PBS under anaerobic conditions.
2.2. Incubation of SOD1 with MG and SDS-PAGE
Two 60 μM samples of unlabelled apo-SOD1SH and E,Zn-SOD1SH
(the metallation state was previously checked by 1D 1H NMR), in
oxygen-free PBS buffer, were divided in 500 μL aliquots. A solution of
1 M of MG (Sigma-Aldrich) was prepared dissolving the α-oxoaldehyde
in PBS and adjusting the pH to 7.1. Consequently, the protein samples
have been exposed to 0 (control), 1, 5 and 30 mM of MG for a period of
5, 24 and 48 h, at room temperature and under anaerobic conditions.
Such range of concentrations has been chosen to be comparable with
that used in the previous studies [27,28]. At the aforementioned time
intervals, a protein fraction was taken from each sample, it was diluted
to 10 μM, and was subjected to a denaturing and reducing SDS-PAGE
using a 3x FSB (150 mM Tris-HCl, 300 mM DTT, 6% SDS, 0.3% bro-
mophenol blue, 30% glycerol, pH 6.8) solution.
With the aim to perform MS experiments, a further incubation of the
protein with MG was performed using two 90 μM samples of unlabelled
apo-SOD1SH and E,Zn-SOD1SH, in oxygen-free PBS buffer. The protein
samples were divided again in 500 μL aliquots, 5 mM of MG solution
were added to each one and were incubated at 37 °C, under anaerobic
conditions. At the time intervals of 1, 5, 24 and 48 h, 10 μL of protein
solution from each sample were subjected to a reducing and denaturing
SDS-PAGE, and the remaining protein samples, were analysed by
MALDI-TOF, after replacing the buffer with 0.02% acetic acid pH 3.8
(suitable for MS measurements), in order to remove the MG and stop
the reaction.
2.3. MS experiments
The aforementioned apo-SOD1SH and E,Zn-SOD1SH samples in
acetic acid 0.02% pH 3.8 were concentrated in the range of 40–60 μM
and were analysed MALDI-TOF on a Bruker Daltonics Ultraflex III
MALDI TOF/TOF instrument. 1 μL of protein sample was mixed with a
1 μL of matrix solution (SA 10 mg/mL in 70:30 [v/v] acetonitrile :
water with 0.1% TFA). Comapass for flexSeries 1.4 was used as data
acquisition software in positive linear mode. The instrument had been
previously calibrated using the Bruker Protein I calibration standard kit
(5000–17000 Da).
The apo-SOD1SH and E,Zn-SOD1SH samples incubated with 5 mM of
MG for 1 h, at 37 °C, have been selected for a further MALDI-TOF
analysis upon digestion with chymotrypsin. The abovementioned pro-
tein samples, along with the corresponding controls, were subjected to
SDS-PAGE (15 μM of protein per well) and the resulting bands were
excised and transferred in 1.5 mL microcentrifuge tubes. Each band
underwent three consecutive washes in 40 μL of acetonitrile for 10 min,
followed by a final wash in 40 μL of 0.1 M ammonium bicarbonate
(AMBIC). The solution was removed and the gel bands were digested
with chymotrypsin (Promega, Madison, WI). Briefly, 10 μL of a 100 ng/
μL of the chymotrypsin dissolved in 25 mM AMBIC supplemented with
10 mM CaCl2 were added to the gel bands. After overnight digestion at
37 °C, the supernatant was recovered and the reaction was stopped
Fig. 3. SDS-PAGE electrophoresis performed on the apo-SOD1SH (left) and
E,Zn-SOD1SH (right) incubated with 5 mM of MG. Lane 2 & 8: control; lane 3 &
9: 1 h; lane 4 & 10: 5 h; lane 5 & 11: 24 h; lane 6 & 12: 48 h.
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adding 1 μL of 10% TFA. For the MALDI-TOF analysis, 0.5 μL of matrix
solution (α-cyano-4-hydroxycinnamic acid (HCCA) 20 mg/mL in 70:30
[v/v] acetonitrile : water with 0.1% TFA) were mixed with 0.5 μL of the
digested protein fragments on an AnchorChip™ target (600 μm Ø). The
instrument was calibrated using the Bruker Peptide calibration standard
kit (1046–3147 Da) and afterwards the spectra were acquired in posi-
tive ion reflectron positive mode over the m/z range 900–4000.
2.4. NMR experiments
Time-resolved NMR experiments were performed at a 950 MHz
Bruker AVANCE III HD spectrometer equipped with a 5 mm TCI triple-
resonance cryoprobe. Samples of [U–15N]-apoSOD1SH (50 μM) and
[U–15N]-E,Zn-SOD1SH (100 μM) in oxygen-free PBS buffer, pH 7.4, 10%
D2O were first analysed in the absence of MG and subsequently mixed
with MG (1 mM final concentration). The reactions were carried out at
37 °C in the NMR spectrometer and monitored by alternating 1D 1H
spectra (zgesgp, 2 min 17 s each) and 2D 1H, 15N SOFAST-HMQC
spectra [42] (sfhmqcf3gpph, 20 min 19 s each). The NMR spectra were
processed with Bruker Topspin and subsequently analysed with Bruker
Dynamics Center to retrieve signal intensities as a function of time and
to perform non-linear curve fitting with a mono-exponential function.
3. Results
3.1. Reaction of SOD1 with MG by SDS-PAGE
Gel electrophoresis, performed under denaturing and reducing
conditions, clearly indicated that MG reacts with SOD1 forming
covalent adducts. Indeed, the exposure of the protein to MG causes an
evident band shift, which is time- and dose-dependent (Figs. 2 and 3).
Such observations are in accordance with those previously described on
Cu,Zn-SOD1 [27,28]. In addition, a somewhat different reactivity is
observed between MG and the two forms of the protein. More precisely,
SDS-PAGE suggested that MG reacts on numerous sites of apo-SOD1SH,
forming a multitude of products with different electrophoretic mobility
and causing the loss of a defined protein band at high concentrations of
MG and/or long incubation times (Figs. 2a and 3), whereas the reaction
of MG with E,Zn-SOD1SH seems to react with less sites, producing a
better-defined protein band that migrates at a higher molecular weight
compared to the unreacted protein (Figs. 2b and 3). Furthermore, the
effects of MG at longer incubation times and higher concentrations are
much more dramatic on apo-SOD1SH, eventually leading to the loss of
any detectable protein band, while in the case of E,Zn-SOD1SH, reaction
with MG under the same conditions led to the formation of the oligo-
meric forms as those previously observed, which are likely covalent
adducts [27,28].
3.2. MALDI-TOF analysis identified MG reaction sites
The effects of MG on SOD1 were also analysed by mass spectrometry
(MALDI-TOF), which resulted in a net gain of molecular weight of SOD1
relative to the unreacted protein. In accordance, the molecular ions of
unreacted apo-SOD1SH and E,Zn-SOD1SH produced major peaks at m/z
ratios of 15823.5 and 15815.8, respectively (Figs. 4a and 5a). The ob-
tained masses are consistent, within the instrumental error, with a
theoretical molecular mass of human SOD1 of 15823.4 Da, calculated
considering the cleavage of the N-terminal methionine, the complete
Fig. 4. MALDI-TOF spectra of control apo-SOD1SH (a), and incubated at 37 °C with 5 mM of MG for 1 h (b), 5 h (c), 24 h (d), and 48 h (e).
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loss of metal ions under MALDI-TOF conditions and the estimated
protein charge at pH 3.8. A minor peak at 15965.5 and 15960.8, re-
spectively, was detected in both samples, possibly belonging to a small
fraction of protein which underwent an unidentified chemical mod-
ification. Protein samples incubated with 5 mM of MG for increasing
amounts of time presented remarkably different mass profiles. In fact,
in both samples, a marked broadening of the main peak was observed,
indicative of the time-dependent formation of multiple MG-SOD1 ad-
ducts (Fig. 4b–e and Fig. 5b–e). In accordance with SDS-PAGE, the
MALDI-TOF data indicated that the apo form of the protein is more
affected by the exposure to MG, as suggested by the peak broadening
and shifting to higher m/z ratios over time, which is more pronounced
in the case of apo-SOD1SH, due to the formation of several forms with
increasing molecular weights (Fig. 4b–e and Fig. 5b–e).
In a higher molecular mass range, in all MALDI-TOF spectra a minor
peak at around 31600–32500 was observed, likely corresponding to a
covalent dimer of SOD1, whose level slightly increased over the reac-
tion time (Figs. S1 and S2).
In the sample of apo-SOD1SH incubated with 5 mM of MG for 1 h,
we observed the presence of a major peak at 15874.7, adjacent to the
peak at 15820.5 that corresponds to the unreacted protein (Fig. 4b).
Similarly, in the spectrum of the E,Zn-SOD1SH there is a distinct peak at
15872.5, next to the peak at 15818.4 (Fig. 5b). The presence of these
peaks indicated that in both cases, during the first hour of incubation
SOD1 reacts preferentially with one MG molecule, which adds 54 Da to
the molecular mass of the protein. Such net gain of molecular weight is
consistent with the formation of methylglyoxal hydroimidazolone (MG-
H1, MG-H2, MG-H3) on the arginine residues [42,43]. After 1 h of in-
cubation with MG, the reacted protein was the predominant species in
the case of the apo-SOD1SH (Fig. 4b), while in the case of E,Zn-SOD1SH,
the unreacted protein was still the predominant species (Fig. 5b), as
further evidence that the apo form has a higher propensity to react with
MG. However, in both cases, the number of MG-protein adducts in-
creased over time, producing species with different molecular weight
and causing the broadening of the peaks due to spectral overlap.
In order to identify which amino acids reacted more likely with MG
within the first hour, the corresponding protein samples were further
analysed by digestion with chymotrypsin, followed by fragment ana-
lysis by MALDI-TOF. The MALDI-TOF analysis performed on the chy-
motryptic digests of apo-SOD1SH revealed that during the first hour of
incubation MG reacted with either R69, R79, or R143 (Fig. 6 and S3).
The same analysis performed on E,Zn-SOD1SH revealed the presence of
MG adducts with R143 only (Fig. 7 and S4).
In addition to the reaction with arginine which adds 54 Da to the
protein mass, literature reported that MG can form a dihydrox-
yimidazolidine intermediate (Fig. 1) with arginine, which causes a
72 Da increment [44]. Furthermore, a 72 Da increment can derive from
the reaction of MG with lysines and cysteines, which are minor MG-
derived adducts [44,45]. Therefore, we further investigated the pre-
sence of digested fragments compatible with such modifications. This
analysis indicated that a 72 Da increment could derive from several
modified arginine, lysine and cysteine residues on both apo-SOD1SH
Fig. 5. MALDI-TOF spectra of control E,Zn-SOD1SH (a), and incubated at 37 °C with 5 mM of MG for 1 h (b), 5 h (c), 24 h (d), and 48 h (e).
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(Fig. S3) and E,Zn-SOD1SH (Fig. S4). However, +72 adducts are less
abundant in the sample with respect to +54 adducts, as indicated by
MALDI-TOF analysis on the intact protein samples after 1 h of reaction.
3.3. Time-resolved NMR reveals protein structural changes
In order to obtain structural insights on the reaction between MG
and the immature forms of SOD1, we performed time-resolved 1H–15N
2D NMR experiments on samples of apo-SOD1SH and E,Zn-SOD1SH in-
cubated with 1 mM MG (Fig. 8a and b). The 2D NMR spectra provide
information at single-residue resolution, which can be retrieved by
signal intensity changes or by chemical shift perturbation. The above
data were recorded in a time-resolved fashion during the reaction (Fig.
S5), and subsequently fitted with a pseudo-first order kinetic model
(Fig. 8c and d). In both experiments, spectral changes were observed
over the course of the reaction. In the case of apo-SOD1SH, we observed
a decrease of intensity of most signals arising from the residues located
in the β-barrel, which is the structured region of the apo protein. Si-
multaneously, a set of signals centred around 8.3 ppm 1H increased in
intensity (Fig. 8a). This region is typical of unfolded polypeptides,
showing that the reaction with MG caused the gradual unfolding of apo-
SOD1SH. Notably, signals from different residues in the folded protein
decreased with different rates (Fig. 8b). This observation can be ex-
plained with the fact that reaction of MG on a given position in the
structure causes a local perturbation that affects the chemical shifts of
the neighbouring residues, but not those of residues far from the
reaction site. Hence, reactions at different positions affect different sets
of signals in the spectra, and the rate of signal disappearance for each
residue is dependent on the number of reaction sites in its proximity.
Indeed, decrease rates plotted as a function of residue number revealed
that some regions of the protein are more affected by MG reaction
(Fig. 9a). Signal loss at 1-h reaction was also plotted to account for fast-
disappearing signals that could not be properly fitted. Mapping the
perturbed regions on the 3D structure revealed potential reaction sites
at close to residues K9, K136, R143 and C146 (Fig. 9c), some of which
are consistent with the MALDI-TOF analysis of the chymotrypsin digest
(Fig. S3).
Interestingly, a different behaviour was observed in the time-re-
solved NMR experiment on E,Zn-SOD1SH, which is a well-folded
homodimer. In this case, only a subset of signals decreased over time,
whereas several other signals remained unperturbed. (Fig. 8b). More-
over, the rates of disappearance of the decreasing signals were more
uniform (Fig. 9b). This suggested a common cause for the signal loss of
residues located at different positions across the protein structure. Si-
multaneously, a second set of signals in the NMR spectra increased in
intensity at a similar rate (Fig. 8d). Notably, these signals are also
present in the spectra of unreacted E,Zn-SOD1SH, and arise from a small
fraction of protein in the monomeric state, which is at the equilibrium
with the homodimer [46]. Consistently, the non-decreasing signals
arise from residues for which neither monomerization nor reaction with
MG cause a change in chemical shift, so that their intensity is propor-
tional to the sum of the two species. The observed pattern of signals
Fig. 6. MALDI-TOF spectra of the chymotryptic digests of control apo-SOD1SH (a) and apo-SOD1SH incubated with 5 mM MG at 37 °C for 1 h (b).
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therefore may still provide information on the location of MG reaction
sites, but also reflects the fact that reaction with MG increases the po-
pulation of monomeric E,Zn-SOD1SH. Mapping the perturbations on the
3D structure confirmed that, indeed, the majority of residues perturbed
by the reaction with MG are located in the β-barrel at the homodimer
interface, whereas β-strands 2 and 3, which are not at the interface, are
not affected (Fig. 9d). Possible reaction sites, such as K136 and C146,
are also identified. These results are also compatible with the MALDI-
TOF data concerning the reaction rate of MG with R143, which was
identified in both samples as a likely reaction site. Indeed, signals
arising from residues close to R143 decrease with a higher rate in the
apo-SOD1SH NMR spectra with respect to those in the E,Zn-SOD1SH
spectra (Fig. S6), suggesting that R143 reacts faster in the demetallated
sample.
4. Discussion
The data obtained in this study indicated that MG has dramatic
effects on the structure of SOD1. Such effects exacerbate with time and
with increasing concentration of MG. The long-term effects are difficult
to be defined and characterized in detail, because they affect the whole
protein structure indistinctly. Thus, we primarily sought to identify the
first reactions that cause structural destabilization of the protein and
that constitute the first steps of a process that leads to the complete
unfolding of the apo-SOD1SH, and to the monomerization of E,Zn-
SOD1SH.
The SDS-PAGE experiments indicated that MG reacts with the apo-
SOD1SH and E,Zn-SOD1SH forming stable adducts with different elec-
trophoretic mobility with respect to the control samples. In the case of
the apo form such effect exacerbates over time and MG concentration,
causing the complete loss of a defined protein band. In accordance with
previous studies [27,28], we observed the formation of higher mole-
cular weight oligomers, resistant to reducing and denaturing condi-
tions, confirming that MG acts even as a cross-linking agent. Such
crosslinking ability could represent a risk factor for the formation of
aggregates, which especially in the case of apo-SOD1SH, are considered
to be related to the onset of the familial amyotrophic lateral sclerosis
(fALS) [35,47,48]. However, the results of a recent study suggested that
glycation inhibits the amyloid aggregation of SOD1 in both, the me-
tallated and the amyloidogenic apo form of the protein [49].
The MALDI-TOF analysis performed on both forms of the undigested
protein is in line with that from SDS-PAGE, indicating that MG is able to
bind at multiple sites within the protein structure, causing the broad-
ening and the shift of the peaks towards higher molecular weights.
During the first hour of incubation under anaerobic conditions, we
observed that MG mainly forms one adduct with both forms of SOD1,
adding 54 Da to the protein mass. This net weight gain is compatible
with the reaction between MG and arginine, which results in the for-
mation of hydroimidazolone (MG-H1, MG-H2, MG-H3), previously
identified on other proteins [43,44]. The MALDI-TOF analysis per-
formed on the chymotryptic digests, indicated that in apo-SOD1SH the
residues which are prone to react with MG are R69-79-143, while in
Fig. 7. MALDI-TOF spectra of the chymotryptic digests of control E,Zn-SOD1SH (a) and E,Zn-SOD1SH incubated with 5 mM MG at 37 °C for 1 h (b).
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E,Zn-SOD1SH only R143 reacts with MG. Overall, the metallated form of
SOD1 has shown to be more resistant to the glycating effects of MG, and
this is likely due to its quaternary conformation which is more struc-
tured, exposing fewer residues to the solvent.
Through NMR we monitored at single residue-level the time course
of the reaction between MG and the protein. Such analysis has shown
that the reaction between the monomeric apo-SOD1SH and MG occurs
at multiple sites and gradually leads to the unfolding of the protein.
This finding is consistent with a previous report, in which however only
the oxidized, i.e. disulfide containing protein, was analysed [49]. Fur-
thermore, NMR experiments demonstrated that exposure to MG causes
monomerization of E,Zn-SOD1SH. It is noteworthy that, upon interac-
tion with MG, in the spectra acquired on apo-SOD1SH, signals arising
from the unreacted protein gradually disappear but no new signals are
observed arising from the reacted protein. This is likely due to the
formation of a multitude of adducts, in which the glycation occurred on
different residues, each causing a different conformational rearrange-
ment and therefore a different set of chemical shifts. In such situation
the concentration of each adduct remains below the detection limit,
thus preventing detection by NMR.
Based on these results, we can propose a mechanism for MG binding
effects, where the structure of SOD1 in both states is destabilized upon
the formation of an initial adduct, most likely upon binding to R143.
This causes a partial loss of the protein tertiary structure and exposes
further residues to the solvent and to the reaction with MG. In this way
a chain of reactions is likely established, which leads to the formation of
a high number of glycations, involving lysine and cysteine residues as
well.
SOD1 is an essential component of the cellular anti-oxidant defence
system. In parallel, a growing number of studies demonstrated the high
susceptibility of neurons to MG toxicity, which acts simultaneously as a
promoting factor for both the formation of AGEs and the increment of
the intracellular oxidative stress [3,21,22,24–26]. The observed un-
folding of apo-SOD1SH, and the monomerization of E,Zn-SOD1SH, both
constitute conformational modifications that prevent the correct ma-
turation of Cu,Zn-SOD1, i.e. the catalytically active form of the enzyme.
Consequently, the structural modifications caused by MG on the
immature states of SOD1 described in this study may contribute to the
loss of the enzymatic activity of Cu,Zn-SOD1 previously observed in
vitro [27,28], and ex vivo [30].
The function of proteins is strictly dependent on their conformation.
Thus, the reaction with a molecule like MG, which is able to form stable
adducts with proteins, perturbing their structural conformation, can
impair their correct function and catalytic activity. The results of this
study describe the effects of MG on the structure of SOD1, and therefore
contribute to the understanding of the mechanism by which MG com-
promises its enzymatic activity, strengthening the link between the
glycating action of MG and the increase of intracellular oxidative stress.
Fig. 8. (a,b) Overlay of the 2D 1H, 15N NMR spectra of apo-SOD1SH (a) and E,Zn-SOD1SH (b) in the absence of MG (black), and during the reaction with 1 MG after
1 h (red) and 12 h (light blue). Representative residues in different states are labelled (N = native, U = unfolded, D = dimer, M = monomer). (c,d) Representative
plots of signal intensity vs. time of the residues of apo-SOD1SH (c) and E,Zn-SOD1SH (d) labelled in a and b, respectively, during the reaction with 1 mM MG. Best-fit
mono-exponential curves are shown as lines of the corresponding colour. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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